Page last updated: 2024-11-01

nitroglycerin and HbS Disease

nitroglycerin has been researched along with HbS Disease in 1 studies

Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Montalembert, M1
Aggoun, Y1
Niakate, A1
Szezepanski, I1
Bonnet, D1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Iron-mediated Vascular Disease in Sickle Cell Disease.[NCT01239901]150 participants (Actual)Observational2009-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for nitroglycerin and HbS Disease

ArticleYear
Endothelial-dependent vasodilation is impaired in children with sickle cell disease.
    Haematologica, 2007, Volume: 92, Issue:12

    Topics: Adolescent; Anemia, Sickle Cell; Brachial Artery; Carotid Artery, Common; Child; Female; Humans; Mal

2007